therapeutic ultrasound < therapy < therapy adherence

Facettes :

List of bibliographic references indexed by therapy

Number of relevant bibliographic references: 10.

Ident.	Authors (with country if any)	Title
000597 (2010)	Stanley Fahn [États-Unis]	Parkinson's disease: 10 years of progress, 1997–2007
000769 (2010)	Pablo Arias [Espagne] ; Jamile Vivas [Espagne] ; Kenneth L. Grieve [Espagne, Royaume-Uni] ; Javier Cudeiro [Espagne]	Controlled trial on the effect of 10 days low‐frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson's disease
000A07 (2009)	Angelika Nebe [Allemagne] ; Georg Ebersbach [Allemagne]	Pain intensity on and off levodopa in patients with Parkinson's disease
000F60 (2007)	Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni]	Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole
001D64 (1999)	Russell H. Swerdlow [États-Unis] ; W. Davis Parker Jr. [États-Unis]	Mitochondrial pathology in Parkinson's disease and implications for therapeutic intervention
002326 (1995)	J. De Pedro-Cuesta [Suède, Espagne] ; I. J. Petersen ; L. Stawiarz [Suède] ; G. Gudmundsson ; G. Gudmundsson ; J. Almazán [Espagne] ; H. Tulinius [Islande] ; H. Johansson [Suède]	High levodopa use in periodically time‐clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology?
002609 (1992)	Guylaine Le Dorze [Canada] ; Louise Dionne [Canada] ; John Ryalls [Canada] ; Marie Julien [Canada] ; Lisa Ouellet [Canada]	The effects of speech and language therapy for a case of dysarthria associated with Parkinson's disease
002706 (1991)	S. W. Pederson [Suède] ; T. Eriksson [Suède] ; B. Öberg [Suède]	Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient
002822 (1989)	G. J. D. Birkmayer [Autriche] ; W. Birkmayer [Autriche]	Stimulation of endogenous L‐dopa biosynthesis — a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)
002A45 (1984)	M. J. E. Davis [États-Unis] ; G. C. Mews [États-Unis] ; G. D. Cope [États-Unis]	TRANSVENOUS ABLATION OF ATRIOVENTRICULAR CONDUCTION FOR REFRACTORY OR MALIGNANT SUPRAVENTRICULAR ARRHYTHMIAS

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "therapy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    therapy
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024